Form 424B5 Asterias Biotherapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to Form 424B5 Asterias Biotherapeutics
May 10, 2016 5:03 PM EDT
BioTime (NYSE: BTX) reported Q1 EPS of ($0.19), $0.05 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $1.43 million.
For earnings history and earnings-related data on BioTime (BTX) click here.
...
More
May 10, 2016 9:32 AM EDT
Asterias Biotherapeutics, Inc. (NYSE: AST) announced the pricing of an underwritten public offering of 5,147,059 units at a public offering price of $3.40 per unit. Each unit consists of one share of common stock and 0.5 of a warrant to purchase a share of common stock at an exercise price of $4.37 per share. The warrants are immediately exercisable and expire on the fifth anniversary of the date of issuance. The shares of common stock and warrants are immediately separable and will be issued separately.
The offering is expected to close on May 13,... More
